LIVE NEWS !!!!
U.S. pharmaceutical company Pfizer (NYSE:PFE) announced the results from the early stage human trial for BNT162b1, its mRNA candidate jointly developed with German biotech firm BioNTech (NASDAQ:BNTX), on Wednesday. The results showed production of neutralizing antibodies in all the patients who were inoculated after 28 days.
Pfizer also has three other mRNA candidates under development.
Gold futures slid 0.16% to $1,777.05 by 12:15 AM ET (5:15 AM GMT), as investors retreated from the safe-haven asset as their appetite for riskier assets increased. Stocks, which usually move in the opposite direction to gold, were up on Thursday.